Related Experiment Videos
Cell-mediated immunity in idiopathic membranous nephropathy
International Archives of Allergy and Applied Immunology
|January 1, 1981
Summary
Idiopathic membranous nephropathy (MN) patients with nephrotic syndrome exhibit impaired cell-mediated immunity (CMI), showing reduced skin reactivity and lymphocyte responses. This immune dysfunction may play a role in the disease
Area of Science:
- Immunology
- Nephrology
Background:
- Idiopathic membranous nephropathy (MN) is a significant cause of nephrotic syndrome in adults.
- Cell-mediated immunity (CMI) plays a crucial role in immune responses and disease pathogenesis.
Purpose of the Study:
- To evaluate cell-mediated immunity (CMI) in patients with idiopathic membranous nephropathy (MN), particularly those with nephrotic syndrome (NS).
- To compare CMI parameters between MN patients with NS, MN patients in remission, chronic proliferative glomerulonephritis (CGN) patients, and healthy controls.
Main Methods:
- Assessed delayed skin reactivity to purified protein derivative (PPD).
- Measured circulating lymphocyte counts and cell-surface markers (T and B lymphocytes).
- Evaluated functional CMI using mitogenic responses to Concanavalin A (Con A) and phytohemagglutinin (PHA).
Main Results:
- MN patients with NS showed reduced skin reactivity to PPD and a lower proportion of T lymphocytes compared to controls.
- Impaired lymphocyte responses (lower Con A and PHA reactivity) were observed in MN patients with NS.
- CMI parameters in MN patients in remission and CGN patients were similar to healthy controls.
Conclusions:
- The majority of MN patients with NS demonstrate impaired cell-mediated immunity.
- These CMI deficits may contribute to the pathophysiology of idiopathic membranous nephropathy.
- Further research is warranted to explore the implications of CMI dysfunction in MN.